Ambica Parmar
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: February 23, 2026
Duration of systemic therapy in patients with metastatic EGFR-mutated non-small cell lung cancer and brain metastases.
Journal: Translational lung cancer research
Published: January 25, 2026
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study.
Journal: JAMA otolaryngology-- head & neck surgery
Published: April 10, 2025
Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: March 22, 2025
Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: September 10, 2024
Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: June 11, 2024
Oropharyngeal Cancer Staging Health Record Extraction Using Artificial Intelligence.
Journal: JAMA otolaryngology-- head & neck surgery
Published: May 16, 2024
A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 08, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Journal: Current oncology (Toronto, Ont.)
Published: January 10, 2024
Enhancing Symptom Screening and Patient Education Among Patients with Metastatic Lung Cancer: a Qualitative Analysis.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: October 22, 2023
Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World Experience.
Journal: Current oncology (Toronto, Ont.)
Published: August 26, 2023
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada.
Journal: Cancer medicine
Published: July 03, 2023
Last Updated: 09/26/2026